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![Sema4D expression on lymphocytes in HF patients and healthy donors.\
Fresh PBMCs from HF patients and healthy donors were double-stained and analyzed by FACS. The region corresponding to lymphocytes (R1) was selected using an FSC-H/SSC-H density plot. Using an FITC-density plot applied to the R1 region, the regions R2 and R3 corresponding to CD3^+^ and CD19^+^ cells, respectively, were defined (upper panels of 5A and 5B). In the PE density plot (middle panels of 5A and 5B), the right region delimits CD3^+^ and CD19^+^ cells with high expression of Sema4D, respectively. PE-conjugated IgG was used as an isotypic control. The percentage of Sema4D^high^ CD3^+^ cells and Sema4D^high^ CD19^+^ cells in healthy donors (HD) and HF patients (HF) were analyzed (lower panels of 5A and 5B). *P* values were obtained using ANOVA followed by a Tukey post test.](pone.0214894.g001){#pone.0214894.g001}

![Sema4D expression on T cell subpopulations in HF patients and healthy donors.\
Fresh PBMCs from HF patients and healthy donors were double-stained and analyzed by FACS. The region corresponding to lymphocytes (R1) was selected using an FSC-H/SSC-H density plot. Using a FITC-density plot applied to the R1 region, the regions R4 and R5 corresponding to CD4^+^ and CD8^+^ cells, respectively, were defined (upper panels of 6A and 6B). In the PE density plot (middle panels of 6A and 6B), the right region delimits CD4^+^ and CD8^+^ cells with high expression of Sema4D, respectively. PE-conjugated IgG was used as an isotypic control. The percentage of Sema4D^high^ CD4^+^ cells and Sema4D^high^ CD8^+^ cells in healthy donors (HD) and HF patients (HF) were analyzed (lower panels of 6A and 6B). *P* values were obtained using ANOVA followed by a Tukey post test.](pone.0214894.g002){#pone.0214894.g002}
